B37 VENTURES
B37 VENTURES is a Pre-seed, Seed and Series A fund in the US writing $10M–$50M checks into AI, Enterprise, Fintech, Healthcare, robotics, iot, biotechnology, engineered-biology, planetary-health, logistics, transportation, warehouse-operations and food-and-beverage.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- AI, Enterprise, Fintech, Healthcare, robotics, iot, biotechnology, engineered-biology, planetary-health, logistics, transportation, warehouse-operations, food-and-beverage
- Check size
- $10M–$50M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2013
- Website
- b37.vc
Thesis
B37 Ventures is a San Francisco-based venture capital firm founded in 2013 that specializes in connecting early-stage technology startups with multinational corporations to foster innovation. Their core strategy involves using a proprietary platform to facilitate strategic partnerships, enabling startups to validate their product-market fit and achieve global scalability, with the primary goal of generating financial returns through equity stakes. B37 Ventures emphasizes a collaborative approach, investing alongside other top-tier VC firms and leveraging insights from direct customer engagement with their corporate partners. They offer capital, strategic guidance, operational support, and access to a network of "Corporate Champions" who are mandated to deploy new technologies. While specific AUM is not disclosed, they manage at least two closed investment vehicles. Their typical deal size ranges from $10 million to $50 million, with a notable $14 million Series A investment in Ansa in April 2024.
Common questions
Does B37 VENTURES invest at the Pre-seed stage?
Yes. B37 VENTURES lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does B37 VENTURES write?
B37 VENTURES writes $10M–$50M checks.
Where does B37 VENTURES invest?
B37 VENTURES invests in the US.